Citrome Leslie (Leslie Citrome)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 52

Top Topics

Roux En Y Gastric Bypass

Bipolar Disorder

Clinical Practice

Top Venues

Current medical research and opinion

Neuropsychiatric disease and treatment

Postgraduate medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jan A Sedway, Mark G A Opler, Citrome Leslie
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response? Current medical research and opinion (2024)
Citrome Leslie, Lisa M DeTora, Dikran Toroser, Angela Sykes, Trevor Lane, Eline Hanekamp, Laura Dormer, Faith DiBiasi, Lise Baltzer
Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publication. Current medical research and opinion (2024)
Citrome Leslie, Lisa M DeTora, Dikran Toroser, Angela Sykes, Trevor Lane, Eline Hanekamp, Laura Dormer, Faith DiBiasi, Lise Baltzer
Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publication. Current medical research and opinion 40 (4) (2024)
Citrome Leslie, Lisa M DeTora, Dikran Toroser, Angela Sykes, Trevor Lane, Eline Hanekamp, Laura Dormer, Faith DiBiasi, Lise Baltzer
Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publication. Current medical research and opinion 40 (4) (2024)
Jan A Sedway, Mark G A Opler, Citrome Leslie
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response? Current medical research and opinion 40 (4) (2024)
Jan A Sedway, Mark G A Opler, Citrome Leslie
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response? Current medical research and opinion 40 (4) (2024)
Jan A Sedway, Mark G A Opler, Citrome Leslie
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response? Current medical research and opinion 40 (4) (2024)
François-Xavier Chalet, Pierre-Philippe Luyet, Cristina Rabasa, Cédric Vaillant, Paul Saskin, Ajay Ahuja, Citrome Leslie
Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgraduate medicine 136 (4) (2024)
Kristen M Ward, Citrome Leslie
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia. Expert opinion on drug safety 23 (4) (2024)
François-Xavier Chalet, Pierre-Philippe Luyet, Cristina Rabasa, Cédric Vaillant, Paul Saskin, Ajay Ahuja, Citrome Leslie
Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgraduate medicine (2024)
François-Xavier Chalet, Pierre-Philippe Luyet, Cristina Rabasa, Cédric Vaillant, Paul Saskin, Ajay Ahuja, Citrome Leslie
Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgraduate medicine 136 (4) (2024)
Citrome Leslie, Mariacristina Castelli, Masami Hasebe, Takaaki Terahara, Justin Faden, Marina Komaroff
Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis. Neuropsychiatric disease and treatment 20 (2024)
Citrome Leslie, Mariacristina Castelli, Masami Hasebe, Takaaki Terahara, Justin Faden, Marina Komaroff
Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis. Neuropsychiatric disease and treatment 20 (2024)
Kristen M Ward, Citrome Leslie
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia. Expert opinion on drug safety (2024)
Citrome Leslie, Lisa M DeTora, Dikran Toroser, Angela Sykes, Trevor Lane, Eline Hanekamp, Laura Dormer, Faith DiBiasi, Lise Baltzer
Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publication. Current medical research and opinion 40 (4) (2024)
Kristen M Ward, Citrome Leslie
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia. Expert opinion on drug safety (2024)
François-Xavier Chalet, Pierre-Philippe Luyet, Cristina Rabasa, Cédric Vaillant, Paul Saskin, Ajay Ahuja, Citrome Leslie
Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgraduate medicine (2024)
Kristen M Ward, Citrome Leslie
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia. Expert opinion on drug safety 23 (4) (2024)
Jan A Sedway, Mark G A Opler, Citrome Leslie
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response? Current medical research and opinion (2024)
François-Xavier Chalet, Pierre-Philippe Luyet, Cristina Rabasa, Cédric Vaillant, Paul Saskin, Ajay Ahuja, Citrome Leslie
Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgraduate medicine 136 (4) (2024)
Tilman Ruff, Margaret A Winker, Rakesh Aggarwal, Lorraine E Ferris, Falko Markus Heinemann, José Florencio F Lapeña, Sanjay A Pai, Edsel B Ing, Citrome Leslie, Murad Alam, Michael Voight, Farrokh Habibzadeh
Chatbots, generative AI, and scholarly manuscripts: WAME recommendations on chatbots and generative artificial intelligence in relation to scholarly publications. Colombia medica (Cali, Colombia) 54 (3) (2023)
Ivo Abraham, Mickael Hiligsmann, Kenneth K C Lee, Citrome Leslie, Giorgio Lorenzo Colombo, Mike Gregg
What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Lisa M DeTora, Trevor Lane, Angela Sykes, Faith DiBiasi, Dikran Toroser, Citrome Leslie
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. Annals of internal medicine 176 (3) (2023)
Ivo Abraham, Mickael Hiligsmann, Kenneth K C Lee, Citrome Leslie, Giorgio Lorenzo Colombo, Mike Gregg
What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Lisa M DeTora, Trevor Lane, Angela Sykes, Faith DiBiasi, Dikran Toroser, Citrome Leslie
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. Annals of internal medicine 176 (3) (2023)
Heidi C Waters, Robert Stellhorn, Maëlys Touya, Heather M Fitzgerald, Sandipan Bhattacharjee, Citrome Leslie
The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data. Journal of medical economics 26 (1) (2023)
John F P Bridges, Joseph F Goldberg, Heather M Fitzgerald, Sanjeda R Chumki, Kathleen Beusterien, Oliver Will, Citrome Leslie
Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling Results. Patient preference and adherence 17 (2023)
Heidi C Waters, Robert Stellhorn, Maëlys Touya, Heather M Fitzgerald, Sandipan Bhattacharjee, Citrome Leslie
The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data. Journal of medical economics (2023)
Roger S McIntyre, Citrome Leslie, Hannah Cummings, Mark S Todtenkopf, Laura A Tan, Marni White, Sarah C Akerman
Opioid antagonism mitigates antipsychotic-associated weight gain: focus on olanzapine. CNS spectrums (2022)
Citrome Leslie, Emily Belcher, Sylvie Stacy, Mark Suett, Marko Mychaskiw, Gregory D Salinas
Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians. Neuropsychiatric disease and treatment 18 (2022)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2022)
Citrome Leslie, Emily Belcher, Sylvie Stacy, Mark Suett, Marko Mychaskiw, Gregory D Salinas
Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study. Patient preference and adherence 16 (2022)
Citrome Leslie, Robert Risinger, Lavanya Rajachandran, Heather Robison
Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed. Advances in therapy (2022)
Citrome Leslie, Robert Risinger, Lavanya Rajachandran, Heather Robison
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed. Advances in therapy 39 (10) (2022)
Carol Paton, Citrome Leslie, Emilio Fernandez-Egea, Olivia Rendora, Thomas R E Barnes
Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit. Therapeutic advances in psychopharmacology 12 (2022)
Lisa M DeTora, Dikran Toroser, Angela Sykes, Christine Vanderlinden, Fiona J Plunkett, Trevor Lane, Eline Hanekamp, Laura Dormer, Faith DiBiasi, Dan Bridges, Lise Baltzer, Citrome Leslie
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. Annals of internal medicine 175 (9) (2022)
Citrome Leslie
Long-acting injectable antipsychotics: what, when, and how. CNS spectrums 26 (2) (2021)
Citrome Leslie, Christine Graham, Adam Simmons, Ying Jiang, Mark S Todtenkopf, Bernard L Silverman, Lauren DiPetrillo, Hannah Cummings, Lei Sun, David McDonnell
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder. Neuropsychiatric disease and treatment 17 (2021)
Richard Jackson, Matthew N Brams, Citrome Leslie, Amber R Hoberg, Stuart H Isaacson, John M Kane, Rajeev Kumar
Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations. Neuropsychiatric disease and treatment 17 (2021)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2021)
Citrome Leslie, Stuart H Isaacson, Danielle Larson, Daniel Kremens
Tardive Dyskinesia in Older Persons Taking Antipsychotics. Neuropsychiatric disease and treatment 17 (2021)
Russell Rosenberg, Citrome Leslie, Christopher L Drake
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies. Neuropsychiatric disease and treatment 17 (2021)
Dominic Pilon, Swapna Karkare, Maryia Zhdanava, John J Sheehan, Aurélie Côté-Sergent, Aditi Shah, Oliver J Lopena, Patrick Lefebvre, Kruti Joshi, Citrome Leslie
Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy. Journal of medical economics 24 (1) (2021)
Citrome Leslie
Binge eating disorder revisited: what's new, what's different, what's next. CNS spectrums 24 (S1) (2020)
Citrome Leslie
Adherence: A challenge for all. International journal of clinical practice 73 (6) (2019)
Citrome Leslie, Joseph P McEvoy, Mark S Todtenkopf, David McDonnell, Peter J Weiden
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatric disease and treatment 15 (2019)
Citrome Leslie
Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International journal of clinical practice 73 (10) (2019)
Citrome Leslie
Psychiatric commentary addressing the article titled "Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus". CNS spectrums 23 (6) (2019)
Kristen M Ward, Citrome Leslie
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management. Neurology and therapy 7 (2) (2018)
Citrome Leslie
Vesicular monoamine transporter type 2 inhibition can lead to effective and tolerable management of tardive dyskinesia. Evidence-based mental health 21 (3) (2018)
Citrome Leslie
Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International journal of clinical practice 71 (11) (2017)
Citrome Leslie
Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International journal of clinical practice 71 (7) (2017)